economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Assets

Roc Oil Company Pty Limited announces the final outcome of the recommended cash offer to the shareholders of Tethys Oil AB

Roc Oil Company Pty Limited announces the final outcome of the recommended cash offer to the shareholders of Tethys Oil AB

creativebharatgroup@gmail.com January 13, 2025
THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA,...
Read More Read more about Roc Oil Company Pty Limited announces the final outcome of the recommended cash offer to the shareholders of Tethys Oil AB
Bynder Showcases Its New and Expanded AI Capabilities at NRF to Help Retailers Drive Personalized Content Experiences OG_NewsReleaseCompanyLogo_93114.jpg

Bynder Showcases Its New and Expanded AI Capabilities at NRF to Help Retailers Drive Personalized Content Experiences

creativebharatgroup@gmail.com January 13, 2025
Amsterdam, Netherlands:   Bynder, a global leader in AI-powered enterprise DAM, is showcasing...
Read More Read more about Bynder Showcases Its New and Expanded AI Capabilities at NRF to Help Retailers Drive Personalized Content Experiences
Parimatch Introduces Exclusive Markets for Nicholas Pooran, Sunil Narine, and Sunrisers Eastern Cape Ahead of SA20 and ILT20 parimatch_logo.png

Parimatch Introduces Exclusive Markets for Nicholas Pooran, Sunil Narine, and Sunrisers Eastern Cape Ahead of SA20 and ILT20

creativebharatgroup@gmail.com January 13, 2025
Parimatch is excited to announce the expansion of its new markets as the highly anticipated SA20...
Read More Read more about Parimatch Introduces Exclusive Markets for Nicholas Pooran, Sunil Narine, and Sunrisers Eastern Cape Ahead of SA20 and ILT20
Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

creativebharatgroup@gmail.com January 13, 2025
Gothenburg, January 13, 2025 – Elicera Therapeutics AB (publ), a clinical stage cell and...
Read More Read more about Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors